DK555389A - Farmaceutisk praeparat - Google Patents

Farmaceutisk praeparat

Info

Publication number
DK555389A
DK555389A DK555389A DK555389A DK555389A DK 555389 A DK555389 A DK 555389A DK 555389 A DK555389 A DK 555389A DK 555389 A DK555389 A DK 555389A DK 555389 A DK555389 A DK 555389A
Authority
DK
Denmark
Prior art keywords
active ingredient
matrix
pharmaceutical preparation
granules
preparation
Prior art date
Application number
DK555389A
Other languages
Danish (da)
English (en)
Other versions
DK555389D0 (da
Inventor
Yohko Akiyama
Hidetoshi Horibe
Minoru Yoshioka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1259674A external-priority patent/JP2893191B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK555389D0 publication Critical patent/DK555389D0/da
Publication of DK555389A publication Critical patent/DK555389A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK555389A 1988-11-08 1989-11-07 Farmaceutisk praeparat DK555389A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28299488 1988-11-08
JP29437988 1988-11-21
JP1259674A JP2893191B2 (ja) 1988-11-08 1989-10-03 放出制御性マトリックス剤

Publications (2)

Publication Number Publication Date
DK555389D0 DK555389D0 (da) 1989-11-07
DK555389A true DK555389A (da) 1990-05-09

Family

ID=27334835

Family Applications (1)

Application Number Title Priority Date Filing Date
DK555389A DK555389A (da) 1988-11-08 1989-11-07 Farmaceutisk praeparat

Country Status (8)

Country Link
EP (1) EP0368247B1 (fr)
AT (1) ATE106239T1 (fr)
AU (2) AU645003B2 (fr)
CA (1) CA2002363C (fr)
DE (1) DE68915695T2 (fr)
DK (1) DK555389A (fr)
HU (1) HU211615A9 (fr)
NZ (1) NZ231281A (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
KR0168849B1 (ko) * 1990-04-12 1999-01-15 요시또시 가즈오 피목 조성물 및 그의 제조방법
US5290569A (en) * 1990-04-12 1994-03-01 Shionogi & Co., Ltd. Coated composition and its preparation process
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
KR0182801B1 (ko) * 1991-04-16 1999-05-01 아만 히데아키 고체 분산체의 제조방법
TW209174B (fr) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
DE4131562A1 (de) * 1991-09-18 1993-03-25 Medac Klinische Spezialpraep Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln)
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
EP0663818A4 (fr) * 1992-09-03 1996-04-24 Ibah Inc Compositions pharmaceutiques destinees a masquer le gout, et procedes de fabrication.
US5700410A (en) * 1992-10-16 1997-12-23 Nippon Shinyaku Co., Ltd. Method of manufacturing wax matrices
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
TW282403B (fr) * 1993-08-26 1996-08-01 Takeda Pharm Industry Co Ltd
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1998042323A1 (fr) * 1997-03-25 1998-10-01 Takeda Chemical Industries, Ltd. Inhibiteur de l'urease stabilise
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6423345B2 (en) 1998-04-30 2002-07-23 Acusphere, Inc. Matrices formed of polymer and hydrophobic compounds for use in drug delivery
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
JP4310605B2 (ja) * 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20060275228A1 (en) * 2005-05-09 2006-12-07 Bissett Donald L Skin care compositions containing idebenone
WO2010103539A2 (fr) 2009-03-09 2010-09-16 Dinesh Shantilal Patel Formulation orale de vinpocétine à libération lente
US20130071525A1 (en) * 2010-03-29 2013-03-21 Kaneka Corporation Coating fat composition and particulate composition using the same
BR112021006425A2 (pt) * 2018-10-22 2021-07-27 Ioi Oleo Gmbh aditivo para influenciar a coesão e lubrificação de um pó para compressão mecânica, material comprimido a partir do referido aditivo, artigo moldado, processo para preparação do referido artigo
JP7376582B2 (ja) * 2018-10-22 2023-11-08 イーオーイー オレオ ゲーエムベーハー 成形体への圧縮を目的とした粉末材料用添加剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung
JPS5951214A (ja) * 1982-09-16 1984-03-24 Taiho Yakuhin Kogyo Kk バイオアベイラビリテイの高い薬剤の製造方法
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
CA1331559C (fr) * 1986-04-21 1994-08-23 Jon Joseph Kabara Compositions et methodes pour la conservation antimicrobienne
JP2818220B2 (ja) * 1988-11-04 1998-10-30 フロイント産業株式会社 食品用の含水有機溶剤抽出物含有組成物および医薬用の含水有機溶剤抽出物含有組成物、並びにそれらの製造方法

Also Published As

Publication number Publication date
DE68915695D1 (de) 1994-07-07
AU3856193A (en) 1993-08-26
AU645003B2 (en) 1994-01-06
AU4443789A (en) 1990-06-21
CA2002363A1 (fr) 1990-05-08
NZ231281A (en) 1991-01-29
CA2002363C (fr) 1999-09-07
EP0368247B1 (fr) 1994-06-01
EP0368247A2 (fr) 1990-05-16
DE68915695T2 (de) 1994-09-15
HU211615A9 (en) 1995-12-28
EP0368247A3 (fr) 1991-05-08
ATE106239T1 (de) 1994-06-15
DK555389D0 (da) 1989-11-07

Similar Documents

Publication Publication Date Title
DK555389D0 (da) Farmaceutisk praeparat
GR3004509T3 (fr)
IE871584L (en) Sustained release capsule.
EP0627218A4 (fr) Comprime a solubilite acceleree.
CA2091370A1 (fr) Comprime, granule et pellets en substances actives a teneur elevee pour preparations pharmaceutiques solides tres concentrees
NZ228970A (en) Chewable tablet comprising granules and an extragranular hygroscopic excipient
DE3872739D1 (de) Arzneimittel mit langsamer freisetzung.
IT1187750B (it) Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
ATE179602T1 (de) Stabilisierte, feste pharmazeutische zubereitung, die dextromethorphan phenylpropanolamine und coffein enthält
EP0068450A3 (en) Pharmaceutical forms for oral administration
DK515489A (da) Dispergerbar laegemiddelformulering
ZA87216B (en) A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
MY101916A (en) Etoposide oral dosage form.
JPS52130905A (en) Medicinal composition
EP0367509A3 (fr) Formulations
JPS6413026A (en) Antiviral agent
DE3265827D1 (en) Pharmaceutical composition of phosphonomicin in tablet form
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid
JPS57112327A (en) Antidiabetic agent comprising 2,3-dihydroxypropyl ester of n-(7-chloro-4-quinolyl)anthranillic acid
JPS5659714A (en) Improver and remedy for dysbulia or depression
ITBO920455A1 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato ritardato del principio attivo e le forme farmaceutiche cosi' ottenute.
TH13475A (th) สูตรผสมทางเภสัชกรรม
DE69325531D1 (de) Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen
JPS57112328A (en) Hypotensor comprising 2,3-dihydroxypropyl ester of n-(7- chloro-4-quinolyl)anthranillic acid

Legal Events

Date Code Title Description
A0 Application filed
AHB Application shelved due to non-payment